Search results
26 sie 2022 · ESC Clinical Practice Guidelines aim to present all the relevant evidence to help physicians weigh the benefits and risks of a particular diagnostic or therapeutic procedure on Ventricular Arrhythmias and the Prevention of Sudden Cardiac (SCD).
ARVC indicates arrhythmogenic right ventricular cardiomyopathy; CPVT, catecholaminergic polymorphic ventricular tachycardia; IHD, ischemic heart disease; SCA, sudden cardiac arrest; SCD, sudden cardiac death; SIDS, sudden infant death syndrome; and VA, ventricular arrhythmia.
26 sie 2022 · See the European Heart Journal online for supplementary data that includes background information and detailed discussion of the data that have provided the basis of the guidelines. Click here to access the corresponding ESC CardioMed chapters. 1. Preamble 4003. 2. Introduction 4005. 2.1. What is new 4005. 3. Definitions 4011. 3.1.
2 wrz 2022 · ICD implantation should be considered in symptomatic patients with definite ARVC, moderate right or left ventricular dysfunction, and either nonsustained VT or inducibility of SMVT at EP study. CMR with LGE is recommended in hypertrophic cardiomyopathy (HCM) patients for diagnostic workup.
Latest guidelines value a more patient-individual approach to ICD therapy. Guidelines for the management of patients with ventricular arrhythmias (VAs) and the prevention of sudden cardiac death (SCD) are periodically updated integrating the latest scientific evidence and translating it into clinical practice.
See Sections 7, 10.2, 10.3, 10.8, and 10.9. Defibrillation is highly effective in terminating life-threatening VA. This therapy can be delivered by a transvenous ICD, a subcutaneous implantable cardioverter-defibrillator, a wearable cardioverter-defibrillator or an external defibrillator.
21 paź 2022 · 2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death Eur Heart J . 2022 Oct 21;43(40):3997-4126. doi: 10.1093/eurheartj/ehac262.
